Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence.
Tanya Barauskas DorffSheetal R KashidVedang MurthyRiccardo LombardoCosimo De NunzioPublished in: Prostate cancer and prostatic diseases (2024)
The systematic review by Saouli et al. investigates the role of radical prostatectomy (RP) in managing oligometastatic prostate cancer (omPCa) [1]. They analyzed the existing literature to assess the oncological and functional outcomes of RP for these patients. RP is feasible and has an acceptable risk of complications. However, the lack of consensus on the definitions of omPCa and the low-quality evidence of the available comparative and retrospective studies, RP in omPCa should not be recommended outside of clinical trials.
Keyphrases
- radical prostatectomy
- prostate cancer
- systematic review
- clinical trial
- end stage renal disease
- newly diagnosed
- ejection fraction
- meta analyses
- chronic kidney disease
- robot assisted
- cross sectional
- patient reported outcomes
- clinical practice
- open label
- quality improvement
- minimally invasive
- patient reported
- study protocol